US Patent 10253059 Hybrid galactoside inhibitor of galectins
Patent 10253059 was granted and assigned to Galecto Biotech on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 6, 2015
Date of Patent
April 9, 2019
Patent Applicant
Patent Application Number
15323967
Patent Inventor Names
Ulf Nilsson
0
Fredrik Zetterberg
0
Hakon Leffler
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10253059 Hybrid galactoside inhibitor of galectins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.